The cause of hypertension is unknown in nearly 95% of cases.
1 Additionally, most forms of essential hypertension become more severe as patient's age and age-related changes in the cardiovascular system may contribute to this phenomenon.
1 Telomere shortening has been found in vascular endothelial cells, smooth muscle cells and cardiomyocytes during aging. 2 Thus, the purpose of this study was to compare the telomere length of hypertensive patients and control subjects from the community.
The institutional review board of a teaching hospital approved the protocol for this study and informed consents were obtained from all participants. We consecutively collected 73 hypertensive patients from the outpatient department at a teaching hospital in southern Taiwan, from November 2002 to August 2003. Patients were placed in the hypertension group if they were on any antihypertensive medication and had a systolic measured blood pressure greater than or equals to 140 mm Hg, and/ or a measured diastolic blood pressure more than or equals to 90 mm Hg in the clinic records as defined by the criteria of the World Health Organization. 3 The control subjects were a stratified random sample selected from the general population in Tainan, a city in southern Taiwan, 40 km from where the case group was recruited. Of the 1231 participants invited for the health-screening program, 429 agreed to participate. Only participants that were within the age range of subjects were included. Therefore, 76 control subjects above the age of 45 were selected for the control group. No anthropometric or BP measurements were made in the control subjects, thus there could be hyptertensive patients in the control group.
Genomic DNA was prepared from peripheral blood for DNA extraction. This study used 0.5 ml of whole-blood and NucleoSpin blood kit (Macherey-Nagel, Germany) to extract the genomic DNA following the manufacturer's recommendations. The telomere was measured using a TeloTAGGG Telomere Length Assay (Roche, Mannheim, Germany). The DNA was digested with HinfI and RsaI for 2 h. After electrophoresis, the digested DNA products were transferred to a nylon membrane by a vacuum blot apparatus (Pharmacia LKB, Vacu Gene XL, Uppsala, Sweden). The blot membrane was hybridized with a probe that was detected by chemiluminescence. The membrane was exposed to X-film for 5-15 min. The mean terminal restriction fragment (TRF) length was calculated by formula TRF ¼ P
, where OD i is the chemiluminescence signal and L i is the length of the TRF fragment at the position i.
Telomere length was also measured using a realtime PCR method, as described by Cawthon. 4 Following the standard selection criteria suggested by Cawthon, 4 eight non-hypertensive male subjects that were in the age range of the case group were selected as the reference samples for the establishment of real-time PCR platform. The real-time PCR methodology was based on a previous study published by Gil 5 using R.A.P.I.D. CE7200 system (Idaho Technology, Salt Lake City, UT, USA). The primer sequences used for the telomeres and the singlecopy gene 36B4 (encodes acidic ribosomal phosphoprotein) were tel F, 5
0 . The PCR reaction used a LightCycler FastStart DNA Master SYBR Green Kit (Roche, Mannheim, Germany), with 3 mM Mg 2 þ in 20 ml final volumes. The final primer concentration of telomeres and 36B4 were 0.2 and 0.3 mM, respectively. PCR was performed on a real-time PCR machine (RAPID, ID, Salt Lake City, UT, USA). The thermal cycling profile for the telomere amplification was 95 1C for 10 min, followed by 20 cycles of
Data were analyzed using the SPSS 10.0. All variables were analyzed using primary descriptive statistics. In addition, linear regression analysis and logistic regression were used to establish the predictive model of telomere length and explore the relationship between telomere length and hypertension. Among the 73 hypertensive patients, 40 were men (54.79%). There were no significant differences between the cases and controls for age and sex (P ¼ 0.163 and P ¼ 0.165, respectively).
We found that telomere lengths declined with age as expected (t ¼ À2.352, P ¼ 0.02). The association between sex and telomere lengths was not statistically significant (P ¼ 0.245; data not shown). Since telomere length was inversely related to chronological age and was greater in women than in men, the effects of age and sex were controlled to obtain an absolute relationship between hypertension and telomere length. Comparing the hypertensive patients with the community subjects, the telomere lengths of the hypertensive patients were found to be shorter than those of the community subjects (OR ¼ 1.38, 95% CI ¼ 1.16-1.65, Po0.001; Table 1 ). Parsimonious logistic regression analysis showed that each kb decrease in telomere length equaled an increase of 1.4 times in the risk of hypertension (OR ¼ 1.4, 95% CI ¼ 1.183-1.667, Po0.001; data not shown). Within the hypertension group, time, after diagnosis, was not significantly associated with telomere length (b ¼ À0.08, P ¼ 0.482; Table 2 ).
We found that the telomere length of hypertensive patients was shorter than that of the community subjects. This result was also observed in the study of Demissie et al. 6 Therefore, it is reasonable to hypothesize that telomerase, a reverse transcriptase that elongates telomeres through the de novo synthesis of TTAGGG repeats, was more inactive in hypertensive patients. However, Tristano et al. 7 showed that telomerase activity was higher in patients under 45 years old with poorly controlled hypertension. Even in the presence of telomerase, cells with short telomeres have limited tissue renewal capacity. 8 To date, the influence of telomerase in hypertension is not clear.
One of the limitations in our study was that the control group is a stratified random sample selected from the general population, thus could include up to 27% of people with hypertension, as suggested by the prevalence world wide. 9 However, our results shows that the comparison between a the control and case group still remains significant.
In conclusion, this study reported that there is an association between telomere length and hypertension, with age and gender adjusted. Therefore, the question whether telomere length or hypertension affects remains unanswered. In addition, hypertensive patients have nine times greater risk of being depressed, 10 and depression has an effect on telomeric shortening.
11 Depression could be a confounder of the relationship between telomere length and hypertension; however, further investigation of this topic may be warranted. Besides depression, hypertension also increases the association within insulin resistance, oxidative stress and shorter leukocyte telomere length. 12 For better understanding of the correlation between telomere length and vascular aging in humans, we propose that a larger-scale study be carried out to explore further the relationship between telomere length and hypertension. What this study adds: K This study shows that telomere length may be a mediating covariate for an accelerated deterioration of the cardiovascular system in cancell individuals with essential hypertension. K This study is a pilot study for understanding of the role of telomere length in hypertension in Chinese population.
